Your browser doesn't support javascript.
loading
Identifying Profiles of Patients With Uncontrolled Type 2 Diabetes Who Would Benefit From Referral to an Endocrinologist.
Avnat, Eden; Chodick, Gabriel; Shalev, Varda.
Afiliación
  • Avnat E; School of Public Health, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel. Electronic address: edenavnat@mail.tau.ac.il.
  • Chodick G; School of Public Health, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; Maccabi Data Science Institute, Maccabi Healthcare Services, Tel Aviv, Israel.
  • Shalev V; School of Public Health, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; Maccabi Data Science Institute, Maccabi Healthcare Services, Tel Aviv, Israel.
Endocr Pract ; 29(11): 855-861, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37595841
ABSTRACT

OBJECTIVE:

To compare the outcomes of glycemic uncontrolled diabetes mellitus type 2 patients receiving treatment from endocrinologists with those treated by primary care physicians. Additionally, this research aims to identify patient profiles that would benefit from personalized referral-a novel medical approach that aims to match the most suitable specialist for effectively managing patient while considering the patient's profile.

METHODS:

This retrospective cohort study uses the Maccabi Healthcare Services diabetes registry to match 508 pairs of glycemic uncontrolled diabetes mellitus type 2 patients treated by endocrinologists (EndoG) and primary care physicians (PcPG). Using a generalized additive model, we analyzed the hemoglobin A1c (HbA1c) trend over 1 year for each group. We employed the odds ratio (OR) from conditional logistic regression to determine the likelihood of favorable outcomes in the EndoG compared to the PcPG, using the entire cohort and subcohort profiles.

RESULTS:

The generalized additive model comparison indicated an improvement in HbA1c levels in both groups, with the EndoG outperforming the PcPG. Furthermore, the EndoG group had an OR = 2.27 (95% confidence interval, 1.6 to 3.2) for reducing HbA1c by at least 1% within a year and an OR = 1.68 (95% confidence interval, 1.02 to 2.76) for achieving low-density lipoprotein levels< 100 mg/dl. We identified 96 profiles with positive outcomes, all favoring treatment by endocrinologists.

CONCLUSIONS:

EndoG demonstrated superior HbA1c control over time and achieved better outcomes compared to PcPG. The identification of 96 profiles benefiting from endocrinologist referral emphasizes the potential of personalized referral.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Endocr Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Endocr Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article